Tech
Deciphex, an Irish company that develops software to accelerate the delivery of pathology services, has raised $11.5 million from backers that include pharma giant Novartis and contact research organisation Charles River Laboratories. Dublin-based Act Venture Capital led the latest financing which brings total funding to date for Deciphex to $19.5 million. Other participants in the Series B found include Irrus Investments, Nextsteps Capital and the HBAN Medtech Syndicate.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: